课题基金 / 基金详情

CARDIOTOXICITY OF STREPTOCOCCAL PYROGENIC EXOTOXINS

CARDIOTOXICITY OF STREPTOCOCCAL PYROGENIC EXOTOXINS
链球菌热原性外毒素的心脏毒性
批准号:
2218234
负责人:
Patrick M Schlievert
金额:
$13.71万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 1997-08-31

项目摘要

项目成果

Patrick M Schlievert的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cardiac complications including cardiomyopathy and endocarditis frequently complicate HIV infections particularly late in the course of the disease. Injection drug users infected with HIV are the most commonly affected. The etiology of HIV-related cardiotoxicity is unclear, although some believe it is related to concurrent infection with other bacterial and viral pathogens. This grantee is studying the cardiotoxicity of streptococcal pyrogenic enterotoxins and staphylococcal endotoxins on the heart. The long term goals of this project are two fold: 1) to evaluate the role of streptococcal pyrogenic exotoxins in causing both acute toxic shock line illnesses and delayed sequelae such as acute rheumatic fever and vascular diseases and 2) to analyze the structure function relationships among the streptococcal pyrogenic enterotoxins and staphylococcal enterotoxin. It is hoped that the latter studies will ultimately clarify the molecular mechanism of action of the toxins. R01HL42125 The objective of this program is to continue and expand ongoing studies on the mechanism by which pyrimidine nucleoside analog active against HIV such as 3'azido-3'-deoxythymidine and congeners exert toxicity on bone marrow and other cells. The elicitation of these mechanisms may permit the development of a combination therapy with modulating agents that protect or reverse host toxicity without impairment of the anti-HIV activity of the drug under scrutiny. This project has two major aims: 1) the description of the biochemical and molecular mechanism responsible for the effects of AZT and its metabolite, 3'-amino-3'-deoxythymidine (AMT) in human marrow cells; and 2) the detailed characterization of the enzymatic reduction of AZT to AMT in human hepatocytes with the evaluation of potential drug-drug interactions through the cytochrome P- 450 pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Staphylococcal superantigen and anthrax inhibitors
  • 批准号:
    8376957
  • 项目类别:
  • 资助金额:
    $31.07万
  • 财政年份:
    2012
  • 负责人:
    Patrick M Schlievert
  • 依托单位:
Staphylococcal superantigen and anthrax inhibitors
  • 批准号:
    8233349
  • 项目类别:
  • 资助金额:
    $76.1万
  • 财政年份:
    2011
  • 负责人:
    Patrick M Schlievert
  • 依托单位:
Staphylococcal superantigen and anthrax inhibitors
  • 批准号:
    7672097
  • 项目类别:
  • 资助金额:
    $68.57万
  • 财政年份:
    2009
  • 负责人:
    Patrick M Schlievert
  • 依托单位:
MWCE: Transmission/Pathogenesis of Bioterrorism Agents
  • 批准号:
    6698883
  • 项目类别:
  • 资助金额:
    $68.31万
  • 财政年份:
    2003
  • 负责人:
    Patrick M Schlievert
  • 依托单位:
国内基金
海外基金
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
  • 批准号:
    31770069
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    孙宇辉
  • 依托单位: